- Home
- GXAI vs SSKN Comparison
GXAI vs SSKN Comparison
Compare GXAI & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- SSKN
- Stock Information
- Founded
- GXAI 2021
- SSKN 1989
- Country
- GXAI United States
- SSKN United States
- Employees
- GXAI N/A
- SSKN N/A
- Industry
- GXAI
- SSKN Medical/Dental Instruments
- Sector
- GXAI
- SSKN Health Care
- Exchange
- GXAI Nasdaq
- SSKN Nasdaq
- Market Cap
- GXAI 9.3M
- SSKN 8.9M
- IPO Year
- GXAI 2023
- SSKN 2005
- Fundamental
- Price
- GXAI $1.33
- SSKN $1.45
- Analyst Decision
- GXAI
- SSKN Strong Buy
- Analyst Count
- GXAI 0
- SSKN 1
- Target Price
- GXAI N/A
- SSKN $6.00
- AVG Volume (30 Days)
- GXAI 131.3K
- SSKN 127.2K
- Earning Date
- GXAI 11-13-2025
- SSKN 11-13-2025
- Dividend Yield
- GXAI N/A
- SSKN N/A
- EPS Growth
- GXAI N/A
- SSKN N/A
- EPS
- GXAI N/A
- SSKN N/A
- Revenue
- GXAI $694,278.00
- SSKN $30,980,000.00
- Revenue This Year
- GXAI N/A
- SSKN N/A
- Revenue Next Year
- GXAI N/A
- SSKN $9.70
- P/E Ratio
- GXAI N/A
- SSKN N/A
- Revenue Growth
- GXAI 23205.74
- SSKN N/A
- 52 Week Low
- GXAI $1.00
- SSKN $1.24
- 52 Week High
- GXAI $7.50
- SSKN $3.86
- Technical
- Relative Strength Index (RSI)
- GXAI 45.18
- SSKN 46.80
- Support Level
- GXAI $1.04
- SSKN $1.24
- Resistance Level
- GXAI $1.29
- SSKN $1.46
- Average True Range (ATR)
- GXAI 0.12
- SSKN 0.10
- MACD
- GXAI 0.01
- SSKN 0.00
- Stochastic Oscillator
- GXAI 54.29
- SSKN 49.10
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.